H. Lundbeck AS (OTCPK:HLBBF)
$ 6.75 0 (0%) Market Cap: 5.93 Bil Enterprise Value: 5.64 Bil PE Ratio: 13.51 PB Ratio: 1.51 GF Score: 58/100

H Lundbeck A/S R&D Day Transcript

Nov 30, 2023 / 12:30PM GMT
Release Date Price: $4.8
Charl van Zyl;S;President;CEO
H. Lundbeck A

/-&

Good afternoon. Welcome to everyone here. And also, I would like to extend a welcome to those who have joined us also on the live stream event today. So it's really a pleasure to be with you today. And of course, also wonderful to see a number of familiar faces that I also met in my first 90 days since I've joined Lundbeck.

So let me just briefly introduce myself. I'm Charl van Zyl, who -- I've been with Lundbeck now for about 90 days. And of course, many questions I've often received why have I joined Lundbeck? And it's a very simple answer in a way, it's an answer which is, I've always admired Lundbeck for a company that has maintained itself in terms of its strong purpose to solve complex diseases in neuroscience. One of the few companies that has really remained true to its purpose of addressing these severe diseases in neuroscience.

It is, in a sense, also fitting perfectly with my values. How are we thinking about the work we do today that also impacts society in the long term. And

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot